Showing results (101-110 of 247) with videos related to

Sort By:
Pageof 25
Frontiers in Public Health|December 10, 2021
Influence of the First Wave of the COVID-19 Pandemic on Cancer Care in a German Comprehensive Cancer CenterJohanna Kirchberg, Anke Rentsch, Anna Klimova, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2021
Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power predictionNils Peters, Patrick Wohlfahrt, Christian Hofmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2010
Effect of cetuximab and fractionated irradiation on tumour micro-environmentAlina Santiago, Wolfgang Eicheler, Jan Bussink, et al.
BMC Cancer|April 30, 2026
De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI)Annett Linge, Fabian Lohaus, Steffen Appold, et al.
BJU International|July 2, 2026
Ablative radiotherapy in castration-resistant prostate cancerTobias Hölscher, Fabian Lohaus, Lydia Koi, et al.
Frontiers in Oncology|February 1, 2021
Late Side Effects in Normal Mouse Brain Tissue After Proton IrradiationTheresa Suckert, Elke Beyreuther, Johannes Müller, et al.
Oncogene|June 3, 2021
Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54LJacqueline Nathansen, Vasyl Lukiyanchuk, Linda Hein, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2022
Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical settingJohannes Müller, Stefan Leger, Alex Zwanenburg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2015
γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived materialApostolos Menegakis, Cläre von Neubeck, Ala Yaromina, et al.
Scientific Reports|February 25, 2024
Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [<sup>11</sup>C] methionine PET and T1c-w MRIIram Shahzadi, Annekatrin Seidlitz, Bettina Beuthien-Baumann, et al.
Pageof 25